antibody

Documents about antibody

• Integrating fab phage and yeast display through seamless transfer of paired heavy- and light-chain libraries for efficient antibody discovery.#330836NCBI PubMed Central
• Computational and Experimental Antibody Affinity and Diagnostic Accuracy Quantification of SARS-CoV-2 SD2 Major Disulfide Loop Analog#346692bioRxiv / medRxiv
• Study Comparing the Safety of BG9588 (Anti-CD40L Antibody) Against Standard Treatment in Kidney Transplantation#356601ClinicalTrials.gov
• Compensatory Islet Response to Insulin Resistance Revealed by Quantitative Proteomics#389949S-Space: Seoul National University
• Optimization strategies for monoclonal antibody production: advances in simulation and artificial intelligence in bioprocessing.#404592PubMed
• Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and Trastuzumab Deruxtecan.#409297NCBI PubMed Central
• Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine#444759ClinicalTrials.gov
• Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer#448273ClinicalTrials.gov
• Database Searches For The Therapeutic Potential of Antibody-Drug Conjugates In Advanced Colorectal Cancer: A Systematic Review and Meta-Analysis#628353Borealis Dataverse OAI Archive
• Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas#802848ClinicalTrials.gov
• A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer#803057ClinicalTrials.gov
• Antibody functionalized thiolated chitosan stabilized silver nanoparticles as theranostics toward visceral leishmaniasis#818545HAL (France)
• the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines#834765ClinicalTrials.gov
• A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC#840333ClinicalTrials.gov
• Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.#859454ClinicalTrials.gov
• First in Human Study of a Monoclonal Antibody (SOL-116) Targeting BSSL (Bile Salt-Stimulated Lipase), Single and Multiple Dose Parts#862113ClinicalTrials.gov
• Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer#863119ClinicalTrials.gov
• Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease#866760ClinicalTrials.gov
• Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP#872206ClinicalTrials.gov
• Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers#872843ClinicalTrials.gov
• A Study of ES014 (Anti-CD39/TGF-β Bispecific Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors#881215ClinicalTrials.gov
• Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma#893973ClinicalTrials.gov
• A Phase II Study of Anti-EGFR Antibody-drug Conjugate (ADC) Combine With CDK4/6 Inhibitors Posterior Line in the Treatment of Recurrent/Metastatic CDKN2A Gene Variant Head and Neck Squamous Cell Carcinoma#813932ClinicalTrials.gov
• Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer#852284ClinicalTrials.gov
• A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)#862150ClinicalTrials.gov
• QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer#875836ClinicalTrials.gov
• B cells and humoral immunity in melanoma: regulatory and autoimmune-like features and implications for immunotherapy#4577Europe PMC
• Deep learning assessment of nativeness and pairing likelihood for antibody and nanobody design with AbNatiV2.#9663PubMed
• Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial#145054HAL (France)
• Evaluation of AI Chatbot Responses to a Standardized Patient Query on Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Cross-Sectional Content Analysis.#145942NCBI PubMed Central
• Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300)#152079Unpaywall
• Immunoaffinity biosensors for deoxynivalenol determination from wheat sample: the evaluation of antibody immobilization route and surface topography on the sensor performance.#182554NCBI PubMed Central
• Evaluating pozelimab in the treatment of CHAPLE disease#194886Recep Tayyip Erdoğan University Institutional Repository
• Combination therapy with a novel CD2-targeted costimulatory bispecific antibody overcomes limitations of CD3 T cell engager treatment for solid tumors.#285110NCBI PubMed Central
• The Germinal Center Blueprint for Spatial Immune Mapping and Antibody Discovery in Breast Cancer Sentinel Lymph Nodes#291085Digital Commons @ UConn
• Molecular Characterisation, Isolation, and Antibody Response to Influenza D Virus in Naturally Infected Cattle#350790HAL (France)
• Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy#369835ClinicalTrials.gov
• Bispecific antibody against sclerostin and DKK1 improves bone health and reduces bone marrow adipose tissue accumulation in experimental chronic kidney disease.#375431NCBI PubMed Central
• A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)#390919ClinicalTrials.gov
• Targeting the interleukin‐7 receptor alpha by an anti‐CD127 monoclonal antibody improves allergic airway inflammation in mice#398801HAL (France)
• A Critical Role for Induced IgM in the Protection against West Nile Virus Infection#403260OpenAlex
• Delayed Recognition of Glycoprotein IIb/IIIa Antibody-Associated Platelet Dysfunction in Chronic Liver Disease: A Platelet-Mediated Bleeding-Thrombosis Dysregulation.#439123NCBI PubMed Central
• Longitudinal analysis of drift in the circulating human antibody repertoire over four years#485085Europe PMC
• Dataset associated with the article 'Affordable mobile microfluidic diagnostics: minimum requirements for smartphone digital imaging for colorimetric and fluorometric viral antibody detection'#687085University of Reading Research Data Archive
• Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell#810508ClinicalTrials.gov
• BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma#827806ClinicalTrials.gov
• Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab#830806ClinicalTrials.gov
• Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab#834998ClinicalTrials.gov
• A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)#835104ClinicalTrials.gov
• Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety#842466ClinicalTrials.gov